Overview

Pathogenicity: Nasu-Hakola Disease : Pathogenic
Clinical Phenotype: Nasu-Hakola Disease
Position: (GRCh38/hg38):Chr6:41161341 G>-
Position: (GRCh37/hg19):Chr6:41129079 G>-
dbSNP ID: rs386834141
Coding/Non-Coding: Coding
DNA Change: Substitution
Expected RNA Consequence: Substitution
Expected Protein Consequence: Frame Shift
Codon Change: GCG to CGG
Reference Isoform: TREM2 Isoform 1 (230 aa)
Genomic Region: Exon 2

Findings

The A105Rfs variant, a single-nucleotide deletion, creates a frameshift resulting in a premature stop codon after amino acid 187. This variant, in a homozygous state, was found in a German patient affected by Nasu-Hakola disease (Klunemann et al., 2005). This patient began exhibiting personality and behavioral changes in his early 30s. MRI showed leukoencephalopathy with sparing of arcuate fibers, cerebral atrophy, and thinning of the corpus callosum. Basal ganglia calcification was seen on CT.

Neuropathology

Neuropathological characterization is currently lacking. However, imaging revealed typical findings for patients with NHD, including leukoencephalopathy with sparing of arcuate fibers, cerebral atrophy, thinning of the corpus callosum, and basal ganglia calcification (Klunemann et al., 2005).

Biological Effect

Unknown.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

1. Klünemann HH, Ridha BH, Magy L, Wherrett JR, Hemelsoet DM, Keen RW, De Bleecker JL, Rossor MN, Marienhagen J, Klein HE, Peltonen L, Paloneva J. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology. 2005 May 10;64(9):1502-7. PubMed.

Further Reading

No Available Further Reading